Background Several studies have reported that the systemic immune-inflammation index
(SII) is associated with the prognosis of patients with urologic cancers (UCs). The aim of this …

Background and aim: Chronic low-grade inflammation is associated with various health
outcomes, including cardiovascular diseases (CVDs) and cancers. Systemic immune …

Objective Systemic immune-inflammation index (SII) has been reported in numerous studies
to effectively predict the survival outcomes of urinary system cancers; however no …

Purpose: We hypothesized that autophagy inhibition would increase response to
chemotherapy in the preoperative setting for patients with pancreatic adenocarcinoma. We …

Background The systemic immune‐inflammation index (SII) is a recently developed indicator
for systemic inflammatory response. We aimed to explore the association between SII and …

Background and aims Systemic immune-inflammation index (SII) has been recently
investigated as a novel inflammatory and prognostic marker. SII may be used as an indicator …

Abstract Background Metabolic syndrome (MetS), a worldwide public health problem, affects
human health and quality of life in a dramatic manner. A growing evidence base suggests …

Background The systemic immune-inflammation index based on peripheral neutrophil,
lymphocyte, and platelet counts has shown a prognostic impact in several malignancies …

Several studies found that the systemic immune‐inflammation index (SII) is a prognostic
factor for mortality in patients with solid tumors. It is unknown whether an increased SII in …

Objective This study aimed to investigate the clinical prognostic values of the preoperative
systemic-immune-inflammation index (SII) in older patients undergoing non-cardiac surgery …